海外授权交易成医药行业发展重要引擎!该药企业今日高开近15%

制药网
Jul 08

【制药网 市场分析】在全球医药市场的动态格局中,海外授权交易正逐渐成为一股不可忽视的力量,为医药行业注入新的活力与发展契机。7月8日,基石药业与专注肿瘤领域且在欧洲市场深耕百年的生物医药公司 Istituto Gentili(“Gentili”)就舒格利单抗在西欧和英国的商业化达成独家战略合作。基于这一消息,基石药业今日早盘高开近15%,报5.94港元,股价创2023年2月以来新高。根据双方协议,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10